Novartis Intensifies Entresto Defense with FDA Complaint Amid Patent Lawsuits

Novartis' Legal Actions::
Novartis has filed a complaint with the FDA to defend its drug Entresto following a series of patent lawsuits.

Entresto Defense::
The company is doubling down on its defense strategy for Entresto, a drug used to treat heart failure.

Patent Lawsuits Context::
The legal actions are part of a broader effort by Novartis to protect its intellectual property and market position.

Recent M&A Activities::
Novartis is also in advanced talks to acquire MorphoSys, a German cancer drug maker, indicating its active engagement in both legal and acquisition strategies.